Delayed graft function: Risk factors, consequences and parameters affecting outcome—results from MOST, A Multinational Observational Study
Yvon Lebranchu(Académie Nationale de Médecine), Gunnar Tufveson(Uppsala University Hospital), Marianne Soergel(Novartis (Switzerland)), Jeremy R. Chapman(University of Miami), Federico Oppenheimer(Hospital Clínic de Barcelona), Maurizio Salvadori, Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Volker Kliem(Medizinische Hochschule Hannover), Erich Pohanka, A. Böck(Kantonsspital Aarau), Lutz Fritsche(Charité - Universitätsmedizin Berlin), Bertrand Dussol(Aix-Marseille Université)
Cited by 44
Related Papers
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Spectrum of Mutations in Gitelman Syndrome
|Journal of the American Society of Nephrology|2011|239